BlackRock’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$529M Sell
3,845,155
-98,010
-2% -$13.5M 0.01% 1015
2025
Q1
$711M Sell
3,943,165
-90,707
-2% -$16.4M 0.01% 798
2024
Q4
$632M Buy
4,033,872
+40,749
+1% +$6.38M 0.01% 929
2024
Q3
$727M Buy
3,993,123
+45,278
+1% +$8.24M 0.02% 815
2024
Q2
$725M Buy
3,947,845
+2,142,466
+119% +$393M 0.02% 761
2024
Q1
$321M Sell
1,805,379
-4,168
-0.2% -$742K 0.01% 1313
2023
Q4
$224M Buy
1,809,547
+107,303
+6% +$13.3M 0.01% 1562
2023
Q3
$197M Buy
1,702,244
+68,970
+4% +$8M 0.01% 1547
2023
Q2
$192M Sell
1,633,274
-82,821
-5% -$9.72M 0.01% 1602
2023
Q1
$137M Buy
1,716,095
+16,499
+1% +$1.32M ﹤0.01% 1803
2022
Q4
$135M Buy
1,699,596
+134,291
+9% +$10.6M ﹤0.01% 1797
2022
Q3
$109M Sell
1,565,305
-136,017
-8% -$9.48M ﹤0.01% 1890
2022
Q2
$112M Buy
1,701,322
+17,811
+1% +$1.17M ﹤0.01% 1918
2022
Q1
$112M Buy
1,683,511
+78,015
+5% +$5.19M ﹤0.01% 2051
2021
Q4
$112M Buy
1,605,496
+64,110
+4% +$4.48M ﹤0.01% 2128
2021
Q3
$80.5M Buy
1,541,386
+9,040
+0.6% +$472K ﹤0.01% 2320
2021
Q2
$104M Buy
1,532,346
+51,718
+3% +$3.52M ﹤0.01% 2199
2021
Q1
$114M Buy
1,480,628
+73,280
+5% +$5.65M ﹤0.01% 2103
2020
Q4
$84.4M Buy
1,407,348
+210,428
+18% +$12.6M ﹤0.01% 2147
2020
Q3
$51.5M Buy
1,196,920
+87,936
+8% +$3.79M ﹤0.01% 2235
2020
Q2
$45.9M Buy
1,108,984
+282,219
+34% +$11.7M ﹤0.01% 2275
2020
Q1
$35.8M Buy
826,765
+73,935
+10% +$3.2M ﹤0.01% 2248
2019
Q4
$41.7M Buy
752,830
+1,201
+0.2% +$66.5K ﹤0.01% 2454
2019
Q3
$26.1M Buy
751,629
+150,115
+25% +$5.21M ﹤0.01% 2644
2019
Q2
$24.2M Buy
601,514
+546,317
+990% +$22M ﹤0.01% 2718
2019
Q1
$1.82M Buy
55,197
+36,040
+188% +$1.19M ﹤0.01% 3699
2018
Q4
$398K Buy
19,157
+5,568
+41% +$116K ﹤0.01% 4064
2018
Q3
$239K Buy
13,589
+549
+4% +$9.66K ﹤0.01% 4213
2018
Q2
$194K Buy
13,040
+5,607
+75% +$83.4K ﹤0.01% 4254
2018
Q1
$75K Buy
7,433
+6,636
+833% +$67K ﹤0.01% 4334
2017
Q4
$8K Buy
+797
New +$8K ﹤0.01% 4604